Lördag 21 December | 18:23:20 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-08-19 14:30 Kvartalsrapport 2025-Q2
2025-05-18 14:30 Kvartalsrapport 2025-Q1
2025-02-14 N/A Årsstämma
2025-02-14 15:00 Bokslutskommuniké 2024
2024-11-29 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-31 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-05-17 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2024-02-14 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-26 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2023-05-16 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-10-11 - Extra Bolagsstämma 2022
2022-08-29 - Kvartalsrapport 2022-Q2
2022-06-22 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2022-06-21 - Årsstämma
2022-05-27 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-09 - Extra Bolagsstämma 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-13 - Kvartalsrapport 2021-Q2
2021-06-22 - Årsstämma
2021-05-18 - Kvartalsrapport 2021-Q1

Beskrivning

LandFinland
ListaSpotlight
SektorHandel & varor
IndustriDetaljhandel
Eevia Health är verksamma inom life science. Bolaget erbjuder produktionsprotokoll och procedurer för att leverera ekologiska produkter till internationella kunder. Produkterna säljs till företagskunder och inkluderar ingredienser till producenter av kosttillskott, livsmedel och kosmetika på global basis. Produkterna innefattar exempelvis blåbär, chaga-svamp och tallbark. Eevia Health grundades 2017 och har sitt huvudkontor i Seinäjoki, Finland.
2024-06-10 17:02:49

Eevia Health Plc, ("Eevia" or "The Company"), has today published the notice for the Annual General Meeting of Shareholders ("AGM") for June 28, 2024. The AGM will be held at the main office in Seinäjoki, Finland.

For immediate release

Seinäjoki, Finland 10.06.2024

The call for the AGM is made today, June 10th, 2024. The Record date is 17.6.2024. The market deadline for custodians to do temporary registrations is 24.6.2024 at 10:00 (Finnish time). All relevant information for the AGM, including details on how to participate, can be found in the notice, which may also be found together with relevant documents at the current site: https://investor.eeviahealth.com/corporate-governance/general-meetings/

This information is such that Eevia Health Plc is required to make public in accordance with the EU's Market Abuse Regulation (MAR). The information was made public by the Company's contact person above on June 10, 2024, at 16:59 CEST.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc

Email: stein.ulve@eeviahealth.com

Telephone: +358400 22 5967

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forestsnearor above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brandsglobally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts.Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such asbilberry,lingonberry,chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA (https://spotlightstockmarket.com/en/companies/irabout?InstrumentId=XSAT000085FD).

To learn more, please visitor follow Eevia Health on LinkedIn@EeviaHealth.